Dexcom (DXCM) EBT Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,443.00 |
| Dec 31, 2025 | -6.00 |
| Sep 30, 2025 | 1,414.00 |
| Jun 30, 2025 | 1,061.00 |
| Mar 31, 2025 | 936.00 |
| Dec 31, 2024 | -140.00 |
| Sep 30, 2024 | 629.00 |
| Jun 30, 2024 | 2,146.00 |
| Mar 31, 2024 | 2,387.00 |
| Dec 31, 2023 | 7,614.00 |
| Sep 30, 2023 | 786.00 |
| Jun 30, 2023 | 608.00 |
| Mar 31, 2023 | 2,171.00 |
| Dec 31, 2022 | 1,245.00 |
| Sep 30, 2022 | 2,035.00 |
| Jun 30, 2022 | 1,926.00 |
| Mar 31, 2022 | 3,406.00 |
| Dec 31, 2021 | 501.00 |
| Sep 30, 2021 | 2,974.00 |
| Jun 30, 2021 | 3,096.00 |
| Mar 31, 2021 | 2,470.00 |
| Dec 31, 2020 | 2,588.00 |
| Sep 30, 2020 | 5,578.00 |
| Jun 30, 2020 | 1,420.00 |
| Mar 31, 2020 | 2,325.00 |
| Dec 31, 2019 | 1,876.00 |
| Sep 30, 2019 | 1,909.00 |
| Jun 30, 2019 | 754.00 |
| Mar 31, 2019 | 1,706.00 |
| Dec 31, 2018 | -4,731.00 |
| Sep 30, 2018 | 3,078.00 |
| Jun 30, 2018 | 4,066.00 |
| Mar 31, 2018 | 2,448.00 |
| Dec 31, 2017 | 2,942.00 |
| Sep 30, 2017 | 7,354.00 |
| Jun 30, 2017 | 5,411.00 |
| Mar 31, 2017 | 4,830.00 |
| Dec 31, 2016 | 5,040.00 |
| Sep 30, 2016 | 6,004.00 |
| Jun 30, 2016 | 1,979.00 |
| Mar 31, 2016 | 6,693.00 |
| Dec 31, 2015 | 6,408.00 |
| Sep 30, 2015 | 7,140.00 |
| Jun 30, 2015 | 9,311.00 |